OSE Immunotherapeutics

OSE Immunotherapeutics Employee Directory

Biotechnology ResearchPAYS DE LA LOIRE, France51-200 Employees

OSE Immunotherapeutics, société de biotechnologie qui développe des produits first-in-class en immuno-oncologie (IO) et immuno-inflammation (I&I).  
•	Tedopi® (vaccin contre le cancer) : essai de Phase 3 d’enregistrement en 2ème ligne du CPNPC chez des patients HLA-A2+ en résistance secondaire.  D’autres essais, promus par des groupes cliniques en oncologie, de Tedopi® en combinaison en cours dans des tumeurs solides.
•	Lusvertikimab (anticorps monoclonal antagoniste de IL-7R) : résultats positifs d’efficacité de la Phase 2 dans la rectocolite hémorragique; recherche préclinique en cours dans les leucémies.
•	OSE-279 (anti-PD1) : Premiers résultats positifs de l’étude de Phase 1/2 dans les tumeurs solides. 
•	FR104/VEL-101 (anticorps monoclonal anti-CD28) : développé en partenariat avec Veloxis dans la transplantation ; Phase 1/2 dans la transplantation rénale (sous la promotion du CHU de Nantes) ; Phase 1 finalisée avec succès aux US (promoteur Veloxis).
•	Anticorps monoclonaux anti-SIRPα développés en partenariat avec Boehringer Ingelheim (BI) dans les tumeurs solides avancées et les maladies cardiovasculaires, rénales et métaboliques (CVRM) ; résultats positifs de la Phase 1 d’escalade de dose en monothérapie et en association ; démarrage d’une Phase 2 dans les maladies CVRM prévu fin 2024.
•	ABBV-230 (anticorps monoclonal agoniste de ChemR23) développé en partenariat avec AbbVie dans l’inflammation chronique. 
4 plateformes de recherche brevetées:  
•	Plateforme Anticorps monoclonaux pro-résolutifs 
•	Plateforme Points de contrôle myéloïdes 
•	Plateforme BiCKI®
•	Plateforme ARNm thérapeutique

Find OSE Immunotherapeutics employees' phone numbers or email addresses

OSE Immunotherapeutics Global Highlights

Location
Employees

Europe
99

Minus sign iconPlus sign icon
  • France
    96
  • United Kingdom Of Great Britain And Northern Ireland
    1
  • Belgium
    1
  • Switzerland
    1

North America
3

Minus sign iconPlus sign icon
  • United States Of America
    2
  • Canada
    1

Asia
2

Minus sign iconPlus sign icon
  • India
    1
  • Philippines
    1

South America
1

Minus sign iconPlus sign icon
  • Uruguay
    1

OSE Immunotherapeutics's Leadership

  • Stylized image of a person
    N. P.
    Chief Executive Officer
    Phone icon
  • Stylized image of a person
    J. A. P. M.
    Chief Business Officer
    Phone icon
  • Stylized image of a person
    B. V.
    Chief Medical Officer Immuno Oncology
    Phone icon
  • Stylized image of a person
    F. C.
    Chief Medical Officer Immunology
    Phone icon
  • Stylized image of a person
    L. C.
    Chief Of Translational Research And Alliances
    Phone icon
  • Stylized image of a person
    S. C.
    Head Of Clinical Development And Regulatory Affairs
    Phone icon
  • Stylized image of a person
    A. M.
    Head Of Research, Director Of R&d Program
    Phone icon
  • Stylized image of a person
    D. C.
    Chairwoman And Chief Of Strategy And Developement At Ose Immunotherapeutics
    Phone icon

OSE Immunotherapeutics Employee Metrics

100%
50%
0%
2024
2023
  • Program & Project Management
  • Research
  • Engineering
  • Marketing
  • Administrative
  • Other

Contact profiles from OSE Immunotherapeutics

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    N. P.
    Chief Executive Officer
    Phone icon
    Dec 05, 2024
  • Stylized image of a person
    J. A. P. M.
    Chief Business Officer
    Phone icon
    FranceÎle-de-France
    Dec 05, 2024
  • Stylized image of a person
    B. V.
    Chief Medical Officer Immuno Oncology
    Phone icon
    France
    Sep 17, 2024
  • Stylized image of a person
    F. C.
    Chief Medical Officer Immunology
    Phone icon
    Dec 05, 2024
  • Stylized image of a person
    S. C.
    Head Of Clinical Development And Regulatory Affairs
    Phone icon
    Dec 05, 2024
  • Stylized image of a person
    L. C.
    Chief Of Translational Research And Alliances
    Phone icon
    FranceBrittany
    Dec 05, 2024
  • Stylized image of a person
    A. M.
    Head Of Research, Director Of R&d Program
    Phone icon
    FrancePays de la Loire
    Dec 05, 2024
  • Stylized image of a person
    D. C.
    Chairwoman And Chief Of Strategy And Developement At Ose Immunotherapeutics
    Phone icon
    Dec 05, 2024
  • Stylized image of a person
    R. G.
    Director Of Business Development, Global Market And Competitive Intelligence
    Phone icon
    FranceAuvergne-Rhône-Alpes
    Dec 05, 2024
  • Stylized image of a person
    S. J.
    Director Of Clinical Operations
    Phone icon
    Dec 05, 2024

Frequently Asked Questions

What is OSE Immunotherapeutics known for?

Minus sign iconPlus sign icon
OSE Immunotherapeutics was founded in 2012 operates in the Biotechnology Research industry. The company's main headquarters is located in 22, avenue Bénoni Goullin NANTES, PAYS DE LA LOIRE 44200 FR. Explore OSE Immunotherapeutics's company overview page for more information.

What is OSE Immunotherapeutics's most common email format?

Minus sign iconPlus sign icon
OSE Immunotherapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more OSE Immunotherapeutics email formats with LeadIQ.

How many employees does OSE Immunotherapeutics have currently?

Minus sign iconPlus sign icon
OSE Immunotherapeutics has approximately 75 employees as of November 2024. These team members are located across 4 continents, including EuropeNorth AmericaAsia.

Who are OSE Immunotherapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of November 2024, OSE Immunotherapeutics's key employees include:

  • Chief Executive Officer: N. P.
  • Chief Business Officer: J. A. P. M.
  • Chief Medical Officer Immuno Oncology: B. V.
  • Chief Medical Officer Immunology: F. C.
  • Chief Of Translational Research And Alliances: L. C.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.